Business Wire

Loop Energy Fuel Cells to Power Buildings for the First Time in Agreement With Innotest AG

Share

Loop Energy™ (TSX: LPEN), a designer and manufacturer of hydrogen fuel cell-based solutions, announces a commercial agreement with Innotest AG, a Switzerland-based developer of stationary power systems.

The agreement provides the opportunity for Loop Energy's eFlow™ technology to power buildings in Europe for the first time. Innotest has committed to purchase one Loop Energy S300 (30 kW) fuel cell system for integration into its Home Power Energy System. As part of Innotest's growing product range, the Home Power Energy System is intended to be installed into residential and commercial buildings to provide heat and electricity.

The decision to select the 30 kW fuel cell system results from its ability to meet Innotest's stringent and unique performance metrics. Innotest plans to offer the Home Power Energy System in Switzerland and ultimately expand into other European markets. In addition, the companies expect to launch joint initiatives to promote the advantages of powering buildings with hydrogen fuel cells in the coming year.

"Innotest's decision to select Loop Energy's fuel cell solution demonstrates the versatility of our technology," says Loop Energy Chief Commercial Officer, George Rubin. "We are very excited to deliver a fuel cell solution from our existing product line which we believe will provide value to both Innotest and its customers across the European market."

"The climate crisis is requiring us to find innovative and zero-emission solutions to power our buildings and infrastructure," says Innotest Product Manager, Mathias Kreier. "By integrating Loop Energy's fuel cell technology into our Home Power Energy System, we aim to provide reliable and clean power to homes and businesses across Europe, contributing to driving renewable energy dominance and energy independence lifestyle."

Loop Energy President & CEO, Ben Nyland will also announce the partnership today at the Swiss-Canadian Cleantech Innovation Summit, where he is presenting the company's strategy to enter markets in Europe. More information about the summit can be found at: https://www.s-ge.com/en/contact/swiss-canadian-cleantech-innovation-summit

About Innotest AG and Brand Home Power

Innotest AG was founded in 1994 to develop and provide innovative measuring and testing technology. Innotest AG has succeeded in gaining international competence and expertise in the fields of ultrasound and electromagnetic test and measurement processes. The company's activities are research and development, test devices production and energy storage systems integration. Through Home Power, Innotest integrates innovative technologies delivering alternatives to shift renewable-energy surplus between seasons. For more information, please visit https://homepower.ch/.

About Loop Energy Inc.

Loop Energy is a leading designer and manufacturer of fuel cell systems targeted for the electrification of commercial vehicles, including light commercial vehicles, transit buses and medium and heavy-duty trucks. Loop's products feature the company's proprietary eFlow™ technology in the fuel cell stack's bipolar plates. eFlow™ is designed to enable commercial customers to achieve performance maximization and cost minimization. Loop works with OEMs and major vehicle sub-system suppliers to enable the production of hydrogen fuel cell electric vehicles. For more information about how Loop is driving towards a zero-emissions future, visit www.loopenergy.com.

This press release contains forward-looking information within the meaning of applicable securities legislation, which reflect management's current expectations and projections regarding future events. Particularly, statements regarding the Company's expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information, including without limitation the expected future demand for stationary fuel cell power systems for residential and commercial markets, Innotest AG's planned expansion into Europe, the expected fuel efficiency, reliability and performance of the Company's products, the ability of ability of the Company's products to meet Innotest's stringent and unique performance metrics and the Company's expectation of future orders for its products from Innotest AG. Forward-looking information is based on a number of assumptions (including without limitation assumptions with respect the current and future performance of the Company's products and growth in demand for the Company's products from Innotest AG and other customers) and is subject to a number of risks and uncertainties, many of which are beyond the Company's control and could cause actual results and events to vary materially from those that are disclosed, or implied, by such forward‐looking information. Such risks and uncertainties include, but are not limited to, the ability of the Company to execute on its strategy, progress existing and future customers through the Customer Adoption Cycle in a timely way, the realization of electrification of transportation, the elimination of diesel fuel and ongoing government support of such developments, the expected growth in demand for fuel cells for the commercial transportation market and the factors discussed under "Risk Factors" in the Company's Annual Information Form dated March 30, 2021. Loop disclaims any obligation to update these forward-looking statements.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Investor Inquiries:
Bill Zhang | +1 604.222.3400 Ext. 299 | bill.zhang@loopenergy.com
Laine Yonker | +1 646.653.7035 | lyonker@edisongroup.com

Business Inquiries:
George Rubin | +1.604.828.8185 | grubin@loopenergy.com
Luigi Fusi (EMEA) | +39.028457.3048 | luigi.fusi@loopenergy.com

Media Inquiries:
Lucas Schmidt | +1.604.222.3400 Ext. 603 | lucas.schmidt@loopenergy.com

Innotest AG and Brand Home Power Inquiries:
Mathias Kreier | + 4171.970.0970 | Mkreier@innotest.ch

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Starr Insurance Companies Expands in Thailand17.5.2022 22:33:00 CEST | Press release

Starr Insurance Companies (Starr) announced an agreement with FPG Insurance Holdings Limited (HK) (FPG) and local Thai shareholders to purchase FPG Insurance Public Company Limited (FPG Thailand), a Thai non-life insurance company, together with local Thai parties. Starr’s investment will be held by its Bermuda insurance company, Starr Insurance & Reinsurance Limited. The transaction is expected to close in the second quarter of 2022, subject to certain customary closing conditions, including any necessary regulatory approvals. “Thailand is an important, fast-growing insurance market — one of the cornerstones of the Southeast Asia economy,” said Maurice R. Greenberg, Starr’s Chairman & CEO. “Asia is both commercially and culturally important to Starr, as we trace our roots to an American-owned company founded in Shanghai more than 100 years ago. We look forward to serving the needs of local Thai companies and consumers through this new insurance capability.” David Zuellig, FPG regional

Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE -related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting17.5.2022 22:15:00 CEST | Press release

Emendo Biotherapeutics presented the results of its next generation CRISPR-based gene editing approaches for several indications in an oral presentation and three posters at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) held May 16-19, 2022, in Washington, D.C. Emendo presented pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, demonstrating the power of Emendo’s dual technology platforms that enable the development of a highly specific editing composition that demonstrates no off-targets and complete allele specificity. Significantly, the lack of off-target achieved by Emendo’s engineered and optimized OMNI nuclease also eliminated any translocations. Edited patient derived CD34+ cells differentiated normally into neutrophils both in-vitro and in-vivo, showing full engraftment and reconstitution of all blood lineages, as required for the desired therapeutic effect. “ELANE-based

Piper Sandler Advises PETRONAS Chemicals Group Berhad on Acquisition of Perstorp17.5.2022 19:59:00 CEST | Press release

Piper Sandler & Co. chemicals investment banking announced today that it has advised PETRONAS Chemicals Group Berhad (PCG) on its acquisition of Perstorp Holding AB. The transaction Enterprise Value is €2,300 million and base purchase price, less adjusted net debt, is €1,538 million. It is expected to close in Q3 2022 subject to customary closing conditions. PCG is the leading integrated chemicals producer in Malaysia and one of the largest in Southeast Asia. It operates a number of world-class production sites, which are fully vertically integrated from feedstock to downstream end-products. With a total combined production capacity of 12.8 million metric tons per annum (mtpa), it is involved primarily in manufacturing, marketing, and selling a diversified range of chemical products, including olefins, polymers, fertilizers, methanol and other basic chemicals and derivative products. Listed on Bursa Malaysia in 2010 and with more than three decades of experience in the chemicals indust

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods17.5.2022 19:53:00 CEST | Press release

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and toddler foods (under the age of three) on 11th May 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005112/en/ Morinaga Milk obtains the registration of "New Food Ingredient" in China for use of its probiotic Bifidobacterium longum BB536 in infant and toddler foods on 11th May 2022. (Graphic: Business Wire) Following a complex and lengthy registration process, the probiotic strain B. longum BB536 meets the highest standards of safety and regulatory compliance and has now completed the approval process for use as an ingredient in infant and toddler milk and food products for children under three years old in China. “We are extr

Hiro Capital Joins Knollwood and Boost VC With Major Investment in Skybound Entertainment17.5.2022 19:30:00 CEST | Press release

Hiro Capital has invested in Skybound Entertainment in a significant, undisclosed round led by Knollwood Advisory with participation from Boost VC, and follow-on participation from Com2uS and Skydance Entertainment. Skybound Entertainment is home to acclaimed franchises including The Walking Dead, Invincible, and Impact Winter. “There is nothing more powerful than storytelling, and I’m delighted that Hiro has been able to invest in Skybound Entertainment, creators and curators of extremely compelling omniverses,” said Sir Ian Livingstone, Co-Founding Partner of Hiro Capital. “Hiro’s trust in our vision will help us accelerate the evolution of existing hit franchises as well as new content for our fan base around the world,” said Skybound CEO David Alpert. Skybound brings together creators across its multi-faceted business, including comics, interactive games, audio, film, and television (traditional and digital platforms), licensing, and merchandising. Skybound has successfully franchi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom